Mineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026
Globe Newswire•04/08/2026•08:00 ET
0
Whiz Insights
RADNOR, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced it will report its financial results from the second quarter ended June 30, 2026, after the financial markets close on Tuesday, August 11, 2026.
Tuesday, August 11 (th)@ 4:30 p.m. ET Domestic:1-877-704-4453 International:1-201-389-0920 Conference ID:13760792 Webcast: Link
Get started
Create a free account to read the full story.